Treatment of giant cell arteritis | |
---|---|
Patient fact sheet: Giant cell arteritis | Giant cell arteritis and polymyalgia rheumatic: Current challenges and opportunities |
Genetic and Rare Diseases Information Center.
FDA approves Genentech's Actemra for giant cell arteritis | |
---|---|
.